17 Nov 2021 | Value Investing Substack NEWS
BJCORP's highlighted MD&A from their FY21 Annual Report, Ivermectin - Much More Than You Wanted To Know, Shopee overtakes Mercado Libre in LATAM, AQR: Is (Systematic) Value Investing Dead?
 |
This is Value Investing Substack NEWS! Subscribe for free below to get daily market news delivered to your inbox!
HIGHLIGHTS:
If you see one green box, it could mean the ivermectin group just got a little luckier than the placebo group. When you see 26 boxes compared to only 4 red ones, you know that nobody gets that lucky.
This methodology naturally produces very big apparent effects, and the rare studies where ivermectin does worse than placebo are equally exaggerated (one says that ivermectin patients are 600% more likely to end up hospitalized).
But this doesn’t change the basic fact that ivermectin beats placebo in 26/30 of these studies.
Of studies that included any of the endpoints I recorded, ivermectin had a statistically significant effect on the endpoint 13 times, and failed to reach significance 8 times. Of studies that named a specific primary endpoint, 9 found ivermectin affected it significantly, and 12 found it didn’t.
LINKS:
Stocks & Sectors:
Shopee overtakes Mercado Libre to be the top shopping app in LATAM
Compounder Fund: Wise Investment Thesis - 20 Oct 2021 (Fintech)
Macro:
China:
Temasek sells off Chinese tech stocks amid crackdown by Beijing | CEO Morning Brief (Temasek = Singapore’s sovereign wealth fund)
News & Others:
MEDIA:
Stocks & Sectors:
Macro:
News & Others:
Create your profile
Only paid subscribers can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to log in.